The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy ; volume:6 ; number:1 ; day:8 ; month:9 ; year:2023 ; pages:1-21 ; date:12.2023
Communications biology ; 6, Heft 1 (8.9.2023), 1-21, 12.2023
- Urheber
-
Ali, Amr
Mekhaeil, Bassem
Biziotis, Olga-Demetra
Tsakiridis, Evangelia E.
Ahmadi, Elham
Wu, Jianhan
Wang, Simon
Singh, Kanwaldeep
Menjolian, Gabe
Farrell, Thomas
Mesci, Aruz
Liu, Stanley
Berg, Tobias
Bramson, Jonathan L.
Steinberg, Gregory R.
Tsakiridis, Theodoros
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-023-05289-w
- URN
-
urn:nbn:de:101:1-2024013111500184784830
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ali, Amr
- Mekhaeil, Bassem
- Biziotis, Olga-Demetra
- Tsakiridis, Evangelia E.
- Ahmadi, Elham
- Wu, Jianhan
- Wang, Simon
- Singh, Kanwaldeep
- Menjolian, Gabe
- Farrell, Thomas
- Mesci, Aruz
- Liu, Stanley
- Berg, Tobias
- Bramson, Jonathan L.
- Steinberg, Gregory R.
- Tsakiridis, Theodoros
- SpringerLink (Online service)
Ähnliche Objekte (12)
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
Butyrate suppresses demyelination and enhances remyelination
HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells
INPP4B suppresses prostate cancer cell invasion
Hypofractionated radiotherapy for prostate cancer
Innovative radiotherapy techniques for prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Radiotherapy in nodal oligorecurrent prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
SGLT2 and cancer
Editorial: Advances in radiotherapy for prostate cancer
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer